Fox Business - The Power to Prosper
Search Site

Marijn Dekkers

Bayer's plastics chief sees room to raise prices

Bayer suggested there was room to lift prices at its high-tech plastics and chemicals business this year to counter soaring raw material costs that squeezed first quarter margins.The diversified healthcare group's MaterialScience division, global market leader in polycarbonate plastics used in blu-ray discs and car lights, lowered its outlook last month as a result of the soaring costs of petrochemicals such as benzene.But on Friday the unit's top executive, Patrick Thomas, told Reuters it had leeway to combat the problem by raising prices."We're in markets where you can recover as long as the supply-demand balance is at appropriate level," Thomas said in an interview. "The elasticity in the market place is sufficient.""The real concern would be if high benzene prices were to structurally make our materials uncompetitive. That's not true."The unit, which also makes chemicals for insulation foam, constitutes the higher-margin chemicals business that remained after Bayer spun off what is...

Read More

  1. Bayer's Reinhardt to Leave Co With Aim of Joining Novartis

    German chemical and pharmaceutical company Bayer AG (BAYN.XE) said Wednesday Joerg Reinhardt, chief of Bayer HealthCare, won't renew his contract with the company an...

  2. Bayer Buys Schiff Nutrition for $1.2B

    Bayer inked a deal on Tuesday to buy Schiff Nutrition International (NYSE:SHF) for $1.2 billion in an effort to bolster its position in the U.S.The $34-a-share trans...

  3. Bayer CEO: Organic Growth Is Priority, Takeovers Not Ruled Out

    Bayer AG (BAYN.XE) Chief Executive Marijn Dekkers said Thursday organic growth is his priority but didn't rule out acquisitions in the coming years.His statement cam...

  4. Bayer's Confidence Grows As Sales, Profit Rise

    German pharmaceutical and chemical company Bayer AG (BAYN.XE) said Thursday it "is increasingly confident for the rest of the year" after a good first quarter with f...

  5. Bayer CEO Dekkers: Organic Growth Most Important Target

    Bayer AG (BAYN.XE) views organic growth as the chemical and pharmaceutical company's most important target, Chief Executive Marijn Dekkers told journalists late Wedn...

  6. Bayer Sticks To Target Of Doubling Sales In China By 2015-Report

    German pharmaceutical company Bayer AG (BAYN.XE) is sticking to its target of doubling turnover in China by 2015, Chief Executive Marijn Dekkers tells the Frankfurte...

  7. Bayer Swings To 4th-period Net; Sales Up 2%

    Bayer AG, the Leverkusen, Germany, health-care group, swung to a fourth-quarter profit from a year-earlier loss on 2% higher sales. Net income was €397 million ($533...

  1. Bayer Shells Out $1.1B to Buy Conceptus

    In an effort to strengthen its contraceptive portfolio, German drug and chemical maker Bayer unveiled an all-cash deal on Monday to acquire birth-control maker Conce...

  2. Bayer Agrees to Buy Conceptus for $1.1 Billion in Cash

    Bayer AG (BAYRY, BAYN.XE) has agreed to buy Conceptus Inc. (CPTS) for about $1.1 billion (852 million euros) as the health-care firm aims to broaden its women's cont...

  3. Bayer To Buy Conceptus For $1.1 Billion

    Bayer AG on Monday said it will buy Conceptus, Inc. , whose flagship product is a surgery-free permanent birth control method, for $1.1 billion. Bayer intends to ext...

  4. Bayer to buy birth-control devices maker for $1.1 billion

    Germany's Bayer AG has agreed to buy U.S. contraceptive devices maker Conceptus for $1.1 billion, aiming to underpin its position as the world's largest women's heal...

  5. Bayer Earnings Rise; Confirms Outlook

    Bayer AG (BAYN.XE) Thursday confirmed its outlook for the year as it reported a rise in first-quarter earnings, supported by growth at the HealthCare and CropScience...

  6. Bayer Earnings, Sales Rise on HealthCare, CropScience; Confirms Outlook

    Bayer AG (BAYN.XE) Thursday confirmed its outlook for the year as it reported a rise in first-quarter earnings, supported by growth at the HealthCare and CropScience...

  7. Bayer to Raise 2012 Dividend 15% to EUR1.90

    German pharmaceutical and chemical company Bayer AG (BAYN.XE) said Tuesday it plans to increase its dividend for 2012 to 1.90 euros ($2.51) a share from EUR1.65 in 2...

Freebase CC-BY
Source: Marijn Dekkers on Freebase, licensed under CC-BY
Other content from Wikipedia, licensed under the GFDL